White House withdraws Overton FDA nomination over Hill opposition
Published 17 h ago1 sourceEvidence: Reported
The Trump administration has withdrawn Heidi Overton's nomination to lead the FDA, citing insufficient Senate support for confirmation. This signals a shift in the administration's approach to the FDA leadership and may delay or alter regulatory policy direction. The move is a domestic political development with potential downstream effects on drug and device regulation.
AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works
Locations
Entities
Published 17 h ago1 sourceEvidence: Reported
Published 11 h ago1 sourceEvidence: Reported
Published 1 d ago1 sourceEvidence: Reported
Published 2 d ago2 sourcesEvidence: Unknown
Published 4 h ago2 sourcesEvidence: Reported
Published 23 h ago1 sourceEvidence: Reported
Published 9 h ago1 sourceEvidence: Reported
Published 46 min ago1 sourceEvidence: Reported